“Computational drug Cumintrazole-analog for the treatment of mutant BRCA1 and BRCA2 proteins in breast cancer”, Int Curr Pharm J, vol. 4, no. 8, pp. 410–414, Jul. 2015, doi: 10.3329/icpj.v4i8.24021.